JAMA Oncology Author Interviews
Health & Fitness:Medicine
Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer
Interview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. Hosted by Jack West, MD.
Related Content:
Create your
podcast in
minutes
It is Free